Device Trial Radar · NCT07947485
Six-Channel Wearable ECG for Prediction of Hyperkalemia in Hemodialysis Patients
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Nov 12, 2026
Primary completion
Nov 30, 2027
Study completion Nov 30, 2027
Sponsor
- Lead sponsor
- Chungnam National University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Korea Health Industry Development Institute
- First posted
- Nov 19, 2026
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 19 years, up to 79 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Hyperkalemia is a common and potentially fatal electrolyte disorder in patients receiving maintenance hemodialysis, but it is currently detected only by periodic blood tests. This prospective, single-center observational cohort study will evaluate whether T-wave morphology measured with a six-channel wearable electrocardiogram (ECG) patch can identify hyperkalemia (serum potassium greater than 5.0 mEq/L) in these patients. Forty adults on thrice-weekly hemodialysis will wear the device during one dialysis session per month for 6 months. ECG recordings will be compared with serum potassium measured before and after the same dialysis session. No treatment is assigned by the study, and no additional blood draws are required.
Conditions
- Hyperkalemia
- End-Stage Kidney Disease (ESKD)
- Hemodialysis
Interventions
Six-channel wearable ECG patch (SHC-U8)Device
A wearable Holter-type ECG recorder (model SHC-U8, Solmitech Co., Ltd., Republic of Korea) that records six ECG channels from three chest electrodes. The device is attached immediately before dialysis and removed at the end of the session, once per month for 6 months. It is used within its approved indication for ECG recording only; no treatment is assigned.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area under the receiver operating characteristic curve (AUC) of the pre-dialysis T-wave morphology index for discriminating hyperkalemiaTime frame: At each monthly dialysis session for 6 months (6 sessions per participant)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Chungnam National University Hospital
Daejeon, DJ, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.